Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
A.O. Smith
AOS
$8.57B
| $29.2M | 0.04% |
548,281
-865,339
| -61% | -$43M |
|
577
American Tower
AMT
$81.9B
| $29.2M | 0.04% |
148,212
+146,324
| +7,750% | +$25.7M |
|
|
AMED
578
DELISTED
Amedisys
AMED
| $29.2M | 0.04% |
236,767
+14,254
| +6% | +$1.79M |
|
|
DCPH
579
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $29.2M | 0.04% |
1,256,489
+9,849
| +0.8% | +$258K |
|
|
LOGM
580
DELISTED
LogMein, Inc.
LOGM
| $29.1M | 0.04% |
363,733
+204,943
| +129% | +$17.5M |
|
581
First Interstate BancSystem
FIBK
$3.57B
| $29.1M | 0.04% |
731,335
-20,406
| -3% | -$816K |
|
|
ACC
582
DELISTED
American Campus Communities, Inc.
ACC
| $29.1M | 0.04% |
611,118
+232,255
| +61% | +$10.4M |
|
583
Essential Properties Realty Trust
EPRT
$6.67B
| $29.1M | 0.04% |
1,488,749
+460,950
| +45% | +$7.53M |
|
584
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
| $28.8M | 0.04% |
383,500
+4,300
| +1% | +$311K |
|
585
Teck Resources
TECK
$33.9B
| $28.8M | 0.04% |
1,240,965
-1,784,912
| -59% | -$40.2M |
|
586
Telephone and Data Systems
TDS
$3.87B
| $28.7M | 0.04% |
935,457
-139,422
| -13% | -$4.75M |
|
|
INXN
587
DELISTED
Interxion Holding N.V.
INXN
| $28.7M | 0.04% |
430,742
+208,525
| +94% | +$12.9M |
|
|
588
CALL
Zimmer Biomet
ZBH
$19.3B
| $28.7M | 0.04% |
231,750
+185,400
| +400% | +$21.1M |
|
589
Henry Schein
HSIC
$9.86B
| $28.7M | 0.04% |
476,819
+467,489
| +5,011% | +$28.2M |
|
590
PUT
Amgen
AMGN
$238B
| $28.6M | 0.04% |
+150,600
| New | +$28.8M |
|
|
RDUS
591
DELISTED
Radius Health, Inc.
RDUS
| $28.4M | 0.04% |
1,424,429
-396,709
| -22% | -$7.24M |
|
592
Linde
LIN
$225B
| $28.3M | 0.04% |
161,111
+136,162
| +546% | +$22.6M |
|
593
OneMain Financial
OMF
$7.27B
| $28.3M | 0.04% |
892,332
+413,307
| +86% | +$12.8M |
|
594
Church & Dwight Co
CHD
$23.4B
| $28.3M | 0.04% |
396,864
+374,594
| +1,682% | +$24.6M |
|
|
HOME
595
DELISTED
At Home Group Inc.
HOME
| $28.2M | 0.04% |
1,580,729
+316,943
| +25% | +$7.02M |
|
596
Fate Therapeutics
FATE
$279M
| $28.2M | 0.04% |
1,606,254
+1,018,614
| +173% | +$16.1M |
|
|
OPLN
597
CALL
Openlane
OPLN
$4.08B
| $28.2M | 0.04% |
+1,453,100
| New | +$27.4M |
|
|
EFOR
598
Everforth Inc
EFOR
$1.34B
| $28.2M | 0.04% |
444,484
-1,610
| -0.4% | -$101K |
|
599
Norwegian Cruise Line
NCLH
$7.92B
| $28.2M | 0.04% |
513,067
+69,308
| +16% | +$3.57M |
|
|
XEC
600
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $28.1M | 0.04% |
401,900
| – | – |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.